Compare AstraZeneca plc (AZN) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Nuwellis Inc — how do they compare? AstraZeneca plc trades at $158.05 (market cap $248.14B), while Nuwellis Inc trades at $1.5 (market cap $542.80K). The key difference: AstraZeneca plc is far larger — about 457148.1× Nuwellis Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| AZN | NUWE | |
|---|---|---|
Market Cap | $248.14B | $542.80K |
Sector | Health | Technology |
52-Week High | $209.48 | $220.50 |
52-Week Low | $147.06 | $1.42 |
Enterprise Value | $275.41B | -$1.27M |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
